Research
Hormonal
The GLP-1RA/GIPR antagonist MariTide achieved substantial reductions in weight and HbA1c.
MariTide may be an effective option for weight management and glycemic control in patients.
StrongSupportsmedium confidence
The GLP-1RA/GIPR antagonist MariTide achieved substantial reductions in weight and HbA1c.
Why this rating
Supported by clinical trial data.
Source
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey et al. · Peptides · 2025
reviewCited 20×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →